Long-term octreotide treatment of neuroendocrine tumor cell line CNDT2.5 - - GEO DataSets

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Long-term octreotide treatment of neuroendocrine tumor cell line CNDT2.5

Analysis of ileum neuroendocrine tumor (NET) cell line CNDT2.5 treated with octreotide for up to 16 months. Somatostain analog octreotide is used to treat NET patients. Results provided insight into molecular basis of successful octreotide therapy or the development of drug resistance in NETs.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 2 agent, 5 cell line, 3 time sets

Platform:: GPL6244
Series:: GSE24358
8 Samples

Download data: CEL, CHP

DataSet

Accession:: GDS4330

ID:: 4330

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

GEO DataSets

Functional Genomics Studies

Result Filters

Send to:

Links from GEO Profiles

Supplemental Content

Related information

Important Links

Recent activity